MEDICALLY COMPLEX PREGNANCIES
Dr Shelley Wilkinson, Project Officer
Department of Obstetric Medicine,
Mater Mothers’ Hospital &
Associate Professor and Senior Principal Research Fellow,
School of Pharmacy, University of Queensland &
Director & Principal Dietician,
Lifestyle Maternity & Lifestyle Perimenopause
Brisbane, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | November 2025
A/Prof Shelley Wilkinson is an Advanced Accredited Practising Dietitian, Fellow of Dietitians Australia, and a leading Australian researcher in maternal health and implementation science.
She has over 30 years of experience in the field and holds a PhD in Psychology. Her passion is in health service redesign through co-creation and combining the ‘know-what’ of nutrition with the ‘know-how’ of innovative behaviour change techniques.
Currently, she is involved in the implementation and evaluation of the Obstetric Midwifery Group Practice (“OMGP”) model of care and the “4HER” post-pregnancy cardiometabolic health clinic at Mater Mothers’ Hospitals.
She is also the Director and Principal Dietitian at Lifestyle Maternity and Lifestyle PeriMenopause. Here she delivers women-focussed, evidence-based & innovative care designed to empower women with the skills and knowledge to make informed decisions for their well-being.
Assoc Prof Wilkinson has previously held prestigious fellowships, including the NHMRC TRIP fellowship and the Queensland Government-Health Research Fellowship, which focused on improving dietetic care for women with gestational diabetes and optimising service delivery for healthy gestational weight gain.
She has been recognised for her research excellence with six awards in Evidence-Based Practice and Clinical Research.
Source: Supplied
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
-
Causal genes and pathogenic mechanisms underlying gastrointestinal diseases
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
